REPL vs VTR
Replimune Group Inc (REPL) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
REPL does not have a complete income-statement cache yet.
Latest reported VTR revenue for 2024-12-31 was $4.92B. Net income was $88.4M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
REPL currently screens at market cap $825.7M. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the REPL and VTR stock pages for the full models.
Not investment advice.